adult
ferret
weight
g
hous
biocsl
support
servic
agreement
victorian
infecti
diseas
refer
laboratori
ferret
seroneg
hemagglutin
inhibit
hi
titer
current
circul
influenza
viru
strain
use
experi
conduct
approv
csl
limitedpf
anim
ethic
committe
accord
nation
health
medic
research
council
australia
code
practic
care
use
anim
scientif
purpos
byamagata
lineag
virus
passag
allanto
caviti
embryon
hen
egg
store
infecti
viru
measur
tissu
cultur
infecti
dose
assay
use
hemagglutin
readout
ferret
anaesthet
mgkg
ketamin
mgkg
ilium
vv
mixtur
troy
laboratori
inocul
dropwis
deliveri
viru
ml
nostril
infect
ferret
hous
individu
higheffici
particul
arrest
hepa
filter
isol
unit
blood
sampl
obtain
ferret
primari
viru
infect
termin
experi
anim
weigh
visual
inspect
temperatur
measur
daili
use
implant
temperatur
transpond
fit
identif
chip
lifechip
biothermo
digivet
nasal
wash
specimen
collect
store
previous
describ
day
collect
rna
extract
nasal
wash
realtim
revers
chain
reaction
rtpcr
analysi
rna
extract
nasal
wash
previous
describ
total
rna
assay
realtim
rtpcr
influenza
primer
probe
use
sensifast
probe
lorox
onestep
kit
accord
manufactur
instruct
biolin
fast
realtim
system
appli
biosystem
primer
probe
center
diseas
control
prevent
cdc
influenza
viru
realtim
rtpcr
influenza
subtyp
panel
cdc
influenza
b
lineag
genotyp
panel
obtain
influenza
reagent
resourc
avail
http
wwwinfluenzareagentresourceorg
viral
kinet
assess
use
realtim
rtpcr
data
infect
defin
challeng
viru
load
nasal
wash
least
measur
blockingprevent
defin
challeng
viru
load
nasal
wash
measur
coinfect
defin
primari
viru
challeng
viru
load
nasal
wash
least
day
statist
analysi
ferret
infect
challeng
viru
split
group
primari
infect
persist
follow
challeng
primari
infect
subsid
threshold
day
follow
challeng
control
ferret
exclud
time
challeng
start
shed
challeng
viru
peak
shed
calcul
ferret
group
median
valu
determin
differ
median
valu
group
analyz
use
wilcoxon
rank
sum
test
signific
level
set
linear
regress
perform
number
day
challeng
startpeak
shed
challeng
viru
versu
number
day
primari
infect
persist
follow
challeng
confid
interv
ci
gradient
obtain
indic
interv
startpeak
shed
challeng
viru
delay
day
primari
infect
persist
follow
challeng
null
hypothesi
delay
test
signific
level
set
durat
infect
challeng
viru
compar
ferret
first
infect
challeng
heterosubtyp
influenza
virus
challeng
success
correspond
control
ferret
differ
median
valu
analyz
use
wilcoxon
rank
sum
test
signific
level
set
statist
analysi
conduct
use
r
version
investig
viral
interfer
follow
infect
influenza
viru
systemat
assess
influenc
primari
viru
infect
kinet
secondari
viru
challeng
ferret
model
figur
two
interv
day
day
repres
start
peak
viru
shed
respect
upper
respiratori
tract
urt
one
interv
day
correspond
decreas
viru
shed
one
interv
day
reflect
end
viru
shed
seroconvers
typic
occur
day
follow
infect
data
shown
thu
interv
later
interv
day
day
repres
adapt
immun
respons
figur
determin
whether
prior
infect
could
prevent
shed
differ
viru
type
test
ferret
first
infect
influenza
viru
challeng
influenza
b
viru
vice
versa
primari
infect
challeng
b
b
b
b
control
ferret
primari
infect
infecti
viru
shed
defin
realtim
valu
nasal
wash
assay
flu
flu
b
ns
ha
ha
correl
minimum
amount
detect
infecti
viru
vitro
assay
supplementari
figur
infect
measur
previous
transmiss
variou
pattern
shed
observ
challeng
prevent
secondari
infect
coinfect
shorten
secondari
infect
delay
secondari
infect
effect
compar
control
group
figur
individu
viru
shed
data
ferret
shown
supplementari
figur
clinic
sign
weight
loss
fever
symptom
associ
viru
shed
pattern
data
shown
viru
shed
measur
day
challeng
seroconvers
could
reliabl
use
measur
infect
data
shown
differ
outcom
observ
differ
combin
sequenc
viru
infect
figur
supplementari
figur
tabl
primari
infect
viru
day
prior
prevent
secondari
infect
influenza
b
viru
half
ferret
figur
tabl
contrast
anim
first
infect
influenza
b
viru
challeng
viru
coinfect
shed
virus
observ
figur
tabl
prior
infect
influenza
b
viru
protect
ferret
subsequ
infect
viru
ferret
coinfect
figur
tabl
ferret
first
infect
viru
challeng
influenza
b
viru
protect
shed
virus
challeng
figur
tabl
similar
pattern
observ
interv
figur
tabl
prior
infect
viru
prevent
infect
influenza
b
viru
half
ferret
figur
tabl
interfer
observ
order
virus
revers
coinfect
occur
major
anim
figur
tabl
prior
infect
influenza
b
viru
protect
ferret
challeng
viru
day
later
figur
tabl
longer
interv
day
protect
challeng
observ
group
figur
tabl
prevent
challeng
viru
infect
occur
interv
day
primari
viru
detect
day
supplementari
figur
temporari
state
immun
affect
challeng
outcom
may
requir
presenc
primari
viru
anim
shed
secondari
viru
challeng
figur
group
accord
whether
primari
infect
viru
could
detect
urt
sampl
challeng
proxi
presenc
viru
day
challeng
kinet
challeng
viru
shed
compar
group
figur
supplementari
figur
influenza
b
primari
infect
virus
continu
shed
day
challeng
correl
delay
start
figur
peak
figur
shed
challeng
virus
ongo
shed
viru
delay
start
shed
influenza
b
challeng
viru
longer
period
figur
observ
order
virus
revers
figur
ferret
first
infect
viru
display
signific
delay
start
figur
peak
figur
shed
challeng
influenza
b
viru
next
examin
durat
primari
viru
shed
challeng
modifi
challeng
viru
kinet
ferret
first
infect
viru
everi
day
viru
detect
follow
challeng
start
b
viru
shed
delay
day
ci
p
figur
peak
b
viru
shed
delay
day
ci
p
figur
ferret
first
infect
influenza
b
viru
effect
reduc
everi
day
primari
influenza
b
viru
infect
continu
viru
challeng
peak
viru
shed
delay
day
ci
p
figur
evid
delay
start
viru
shed
figur
evid
delay
ferret
first
infect
influenza
b
viru
challeng
viru
vice
versa
figur
figur
data
show
temporari
immun
depend
continu
presenc
primari
viru
respect
viru
sub
type
statist
support
impact
kinet
primari
viru
infect
shed
shorten
regardless
time
secondari
viru
challeng
supplementari
figur
assess
viral
interfer
influenza
virus
common
antigen
epitop
ferret
infect
viru
challeng
viru
vice
versa
supplementari
figur
shortest
interv
day
prevent
challeng
infect
coinfect
occur
anim
irrespect
order
infect
supplementari
figur
tabl
howev
infect
viru
complet
prevent
infect
viru
day
later
ferret
interv
supplementari
figur
tabl
infect
viru
day
prior
viru
challeng
result
coinfect
supplementari
figur
tabl
interv
day
infect
viru
prevent
infect
viru
ferret
supplementari
figur
tabl
signific
delay
start
peak
shed
either
combin
influenza
viru
may
reflect
small
number
ferret
supplementari
figur
ferret
challeng
day
primari
infect
prior
infect
viru
prevent
infect
supplementari
figur
tabl
howev
challeng
viru
clear
rapidli
figur
supplementari
figur
ferret
shed
viru
median
durat
day
compar
day
control
ferret
figur
similarli
ferret
first
infect
viru
infect
viru
day
later
shed
viru
median
day
compar
day
control
ferret
figur
anim
first
infect
viru
infect
viru
interv
statist
signific
delay
reach
peak
viru
shed
day
supplementari
figur
statist
support
delay
start
shed
supplementari
figur
delay
seen
viru
infect
preced
viru
challeng
supplementari
figur
use
ferret
model
human
influenza
demonstr
infect
influenza
viru
prevent
modifi
subsequ
infect
differ
influenza
viru
sub
type
outcom
vari
accord
viru
combin
interv
primari
infect
challeng
prior
infect
antigen
relat
unrel
virus
provid
protect
subsequ
infect
modifi
infect
kinet
challeng
viru
rel
short
exposur
interv
effect
requir
continu
presenc
primari
viru
follow
challeng
heterosubtyp
influenza
virus
primari
infect
challeng
separ
least
week
challeng
viru
rapidli
clear
outcom
depend
viru
combin
indic
hierarchi
influenza
virus
induc
differ
level
temporari
immun
studi
viru
effect
induc
temporari
state
immun
follow
influenza
b
viru
last
viru
data
may
explain
viral
interfer
observ
epidemiolog
studi
influenza
season
studi
use
influenza
strain
requir
confirm
observ
key
find
studi
coinfect
consist
outcom
ferret
viru
pair
exposur
influenza
virus
occur
within
day
human
coinfect
influenza
virus
rare
detect
probabl
reflect
low
prospect
sequenti
exposur
differ
circul
strain
within
short
window
opportun
given
subset
laboratori
routin
subtyp
influenza
virus
potenti
miss
identif
coinfect
coinfect
influenza
virus
may
give
rise
novel
reassort
understand
true
frequenc
likelihood
occurr
import
public
health
reason
multipl
mechan
may
contribut
establish
temporari
state
immun
interv
week
innat
immun
antivir
mechan
may
prevent
delay
secondari
viral
infect
mechan
antigen
independ
may
common
influenza
b
virus
upon
infect
influenza
viru
express
type
interferon
upregul
infect
epitheli
cell
proinflammatori
cytokin
chemokin
releas
cell
innat
immun
system
intrins
antivir
factor
ifitm
ifit
famili
mxa
inhibit
influenza
viru
fusion
replic
directli
interact
viral
protein
viral
rna
recent
studi
also
demonstr
nucleoprotein
influenza
b
viru
interact
nucleoprotein
influenza
viru
limit
polymeras
activ
suggest
viral
intermedi
may
also
inhibit
coinfect
togeth
mechan
may
limit
amount
viru
shed
make
epitheli
cell
refractori
infect
mop
free
viru
phagocytos
infect
cell
preventingreduc
viral
replic
mani
antigenindepend
mechan
reach
peak
level
peak
viru
shed
l
carolan
k
lauri
unpublish
observ
studi
viru
shed
peak
day
infect
persist
day
consist
time
observ
temporari
immun
time
also
impli
lag
day
follow
primari
infect
innat
immun
intrins
antivir
factor
reach
maximum
level
provid
possibl
explan
observ
window
coinfect
crossreact
immun
respons
may
limit
infect
virus
share
epitop
shorten
period
viru
shed
seen
ferret
infect
consecut
influenza
virus
neutral
antibodi
detect
day
inocul
consist
observ
shorten
challeng
infect
day
first
infect
data
shown
previou
studi
infect
heterosubtyp
influenza
virus
separ
week
show
similar
shorten
durat
viru
shed
crossreact
epitop
influenza
b
virus
report
fusion
peptid
hemagglutinin
ha
enzymat
region
neuraminidas
gener
crossreact
cell
yet
investig
observ
protect
chang
kinet
ferret
infect
influenza
viru
challeng
influenza
b
viru
week
later
vice
versa
data
shown
rapid
clearanc
observ
ferret
consecut
infect
influenza
virus
interv
detect
ferret
consecut
infect
influenza
b
virus
suggest
crossreact
lymphocyt
play
major
role
viral
clearanc
experi
understand
challeng
virus
still
infect
respiratori
epithelium
ferret
establish
influenza
viru
infect
interest
viral
fit
wherebi
one
viru
outgrow
anoth
even
success
transmit
new
host
may
import
anoth
studi
ferret
coinfect
virus
viru
transmit
naiv
contact
ferret
show
clear
fit
advantag
ha
receptor
specif
may
also
contribut
viru
studi
infect
cell
urt
lower
respiratori
tract
wherea
influenza
b
virus
use
studi
infect
urt
follow
intranas
infect
data
shown
suggest
broader
receptor
specif
ha
compar
influenza
b
ha
protein
experi
plan
investig
aspect
model
find
impli
temporari
immun
unrel
virus
last
week
less
ferret
period
short
comparison
observ
interfer
epidemiolog
model
studi
individu
level
influenc
suscept
transmiss
predict
consequ
longer
time
frame
level
popul
use
direct
inocul
model
ensur
challeng
control
dose
viru
consist
low
dose
viru
use
mirror
kinet
natur
infect
durat
temporari
immun
may
differ
aerosol
transmiss
model
close
match
period
seen
human
live
attenu
influenza
vaccin
laiv
shown
induc
innat
immun
respons
thu
abil
laiv
induc
viral
interfer
homolog
hetero
sub
typic
virus
rapid
time
frame
also
interest
overal
studi
provid
insight
phenomenon
viral
interfer
provid
first
experiment
evid
hierarchi
among
influenza
virus
induc
temporari
state
immun
previous
suggest
surveil
studi
human
lack
adapt
immun
specif
age
group
like
major
mechan
behind
domin
viru
upon
emerg
howev
studi
suggest
temporari
immun
may
also
contribut
observ
domin
viru
higher
level
infect
seen
mani
countri
induct
nonspecif
local
temporari
state
immun
may
provid
strategi
control
infect
emerg
influenza
virus
absenc
antigenmatch
inactiv
vaccin
